Delirium and extrapyramidal symptoms due to a lithium-olanzapine combination therapy: A case report

Journal of Korean Medical Science

Volumn 20, Issue 4, 2005, Pages 691-694

  Tuglu, Cengiz ^a   Erdogan, Esin ^a   Abay, Ercan ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Antipsychotic Agents; Delirium; Drug Toxicity; Lithium; Neuroleptic; Neurologic Manifestations; Olanzapine

Indexed keywords

EID: 24644437493     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.4.691     Document Type: Article

References (27)

1. Schou M. Lithium treatment at 52. J Affect Disord 2001; 67: 21-32.
2. Sadosty AT, Groleau GA, Atcherson MM. The use of lithium levels in the emergency department. J Emerg Med 1999; 17: 887-91.
3. Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 1988; 3: 18-32.
4. Emilien G, Maloteaux JM. Lithium neurotoxicity at low therapeutic doses. Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports. Acta Neurol Belg 1996; 96: 281-93.
5. Cohen WJ, Cohen NH. Lithium carbonate, haloperidol, and irreversible brain damage. JAMA 1974; 230: 1283-7.
6. Goldman SA. Lithium and neuroleptics in combination: is there enhancement of neurotoxicity leading to permanent sequelae? J Clin Pharmacol 1996; 36: 951-62.
7. Mani J, Tandel SV, Shah PU, Karnad DR. Prolonged neurological sequelae after combination treatment with lithium and antipsychotic drugs. J Neurol Neurosurg Psychiat 1996; 60: 350-1.
8. Normann C, Brandt C, Berger M, Walden J. Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction. Pharmacopsychiatry 1998; 31: 201-4.
9. Chen PS, Yang YK, Yeh TL, Lo YC, Wang YT. Nonketotic hyperosmolar syndrome from olanzapine, lithium, and valproic acid cotreatment. Ann Pharmacother 2003; 37: 919-20.
10. Rosebraugh CJ, Flockhart DA, Yasuda SU, Woosley RL. Olanzapine-induced rhabdomyolysis. Ann Pharmacother 2001; 35: 1020-3.
11. Ghaemi SN, Ko JY. Quetiapine-related tardive dyskinesia. Am J Psychiat 2001; 158: 1737.
12. Bourgeois JA, Kahn DR. Neuroleptic malignant syndrome following administration of risperidone and lithium. J Clin Psychopharmacol 2003; 23: 315-7.
13. Dallocchio C, Mazzarello P. A case of parkinsonism due to lithium intoxication: treatment with pramipexole. J Clin Neurosci 2002; 9: 310-1.
14. Holroyd S, Smith D. Disabling parkinsonism due to lithium: a case report. J Geriatr Psychiat Neurol 1995; 8: 118-9.
15. Prakash R, Kelwala S, Ban TA. Neurotoxicity with combined administration of lithium and a neuroleptic. Compr Psychiatry 1982; 23: 567-71.
16. Engel J, Berggren U. Effects of lithium on behaviour and central monoamines. Acta Psychiatr Scand Suppl 1980; 280: 133-43.
17. Niethammer R, Keller A, Weisbrod M. Delirium syndrome as a side-effect of lithium in normal lithium levels. Psychiatr Prax 2000; 27: 296-7.
18. Omata N, Murata T, Omori M, Wada Y. A patient with lithium intoxication developing at therapeutic serum lithium levels and persistent delirium after discontinuation of its administration. Gen Hosp Psychiat 2003; 25: 53-5.
19. Honig PK, Cantilena LR. Polypharmacy. Pharmacokinetic perspectives. Clin Pharmacokinet 1994; 26: 85-90.
20. Lang EJ, Davis SM. Lithium neurotoxicity: the development of irreversible neurological impairment despite standard monitoring of serum lithium levels. J Clin Neurosci 2002; 9: 308-9.
21. Callaghan JT, Bergstrom RF, Ptak LR, Beasley CM. Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet 1999; 37: 177-93.
22. Prior TI, Chue PS, Tibbo P, Baker GB. Drug metabolism and atypical antipsychotics. Eur Neuropsychopharmacol 1999; 9: 301-9.
23. Wilson DR, D'Souza L, Sarkar N, Newton M, Hammond C. New-onset diabetes and ketoacidosis with atypical antipsychotics. Schizophr Res 2003; 59: 1-6.
24. Selva KA, Scott SM. Diabetic ketoacidosis associated with olanzapine in an adolescent patient. J Pediatr 2001; 138: 936-8.
25. Lindenmayer JP, Patel R. Olanzapine-induced ketoacidosis with diabetes mellitus. Am J Psychiat 1999; 156: 1471.
26. Devinsky O, Bear D, Volpe BT. Confusional states following posterior cerebral artery infarction. Arch Neurol 1988; 45: 160-3.
27. Pearlman CA. Neuroleptic malignant syndrome: a review of the literature. J Clin Psychopharmacol 1986; 6: 257-73.